|
AU2004242430A8
|
|
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
|
|
AU2004200125A1
|
|
Derivatives of Pneumococcal Choline Binding Proteins for Vaccines
|
|
AU9456501A
|
|
In vitro assay for measuring the immunogenicity of a vaccine
|
|
AU4191801A
|
|
Methods of enhancing activity of vaccines and vaccine compositions
|
|
AU4002001A
|
|
High potency recombinant antibodies and method for producing them
|
|
AU3807901A
|
|
Antibody gene therapy with adeno-associated viral vectors
|
|
AU1955001A
|
|
In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
|
|
AU1804901A
|
|
Method of administering fimh protein as a vaccine for urinary tract infections
|
|
AU6100500A
|
|
Fima pilus-based vaccines
|
|
AU6094000A
|
|
Donor strand complemented pilin and adhesin broad-based vaccines
|
|
AU5622800A
|
|
Combined decorin binding protein and outer surface protein compositions and methods of use
|
|
AU1608400A
|
|
Method of treating arthritis with human parvovirus b19 antigens or antibodies against same
|
|
AU1105700A
|
|
Decorin binding proteins dbp a and b and genes encoding them
|
|
AU5958594A
|
|
Method of protection against (streptococcus pneumoniae) with transformed mycobacteria
|
|
CA2110682A1
|
|
Induction of ctl responses to foreign antigens expressed in mycobacteria
|
